Skip to content
Screener

Atossa Therapeutics, Inc. ATOS Q3 2025 earnings

Reported November 12, 2025 · Before market open

EPS-$1.05In line
EPS estimate-$1.05

Next report

Nov 11, 2026 (in 2 months)
EPS estimate-$0.92

FAQ

When did Atossa Therapeutics, Inc. report Q3 2025 earnings?
Atossa Therapeutics, Inc. (ATOS) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Atossa Therapeutics, Inc.'s Q3 2025 revenue and EPS?
Atossa Therapeutics, Inc. reported eps of $-1.05 for Q3 2025.
Did Atossa Therapeutics, Inc. beat estimates in Q3 2025?
EPS beat the consensus estimate of $-1.05 by $0.00.
How did Atossa Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 2000.0% from $-0.05.
Where can I find Atossa Therapeutics, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-276140) and the 10-Q periodic report (0001193125-25-276160) directly on SEC EDGAR. The filing index links above go to sec.gov.